keyword
MENU ▼
Read by QxMD icon Read
search

(Muscle protein breakdown) OR (Muscle protein degradation) OR (Muscle Atrophy)

keyword
https://www.readbyqxmd.com/read/30342225/systemic-bone-loss-impaired-osteogenic-activity-and-type-i-muscle-fiber-atrophy-in-mice-with-elastase-induced-pulmonary-emphysema-establishment-of-a-copd-related-osteoporosis-mouse-model
#1
Manabu Tsukamoto, Toshiharu Mori, Ke-Yong Wang, Yasuaki Okada, Hokuto Fukuda, Keisuke Naito, Yoshiaki Yamanaka, Ken Sabanai, Eiichiro Nakamura, Kazuhiro Yatera, Akinori Sakai
Although it is suggested that chronic obstructive pulmonary disease (COPD) and bone are related, almost all of the pathological mechanisms of COPD-related osteoporosis remain unknown. There is a mouse model showing a deterioration of bone quality after cigarette smoke exposure; however, in smoking exposure models, various factors exist that affect bone metabolism, such as smoking and body weight loss (muscle and fat mass loss). We considered it appropriate to use an elastase-induced emphysema model to exclude factors influencing bone metabolism and to investigate the influence of pulmonary emphysema on bone metabolism...
October 17, 2018: Bone
https://www.readbyqxmd.com/read/30341596/myotonic-dystrophies-targeting-therapies-for-multisystem-disease
#2
REVIEW
Samantha LoRusso, Benjamin Weiner, W David Arnold
Myotonic dystrophy is an autosomal dominant muscular dystrophy not only associated with muscle weakness, atrophy, and myotonia but also prominent multisystem involvement. There are 2 similar, but distinct, forms of myotonic dystrophy; type 1 is caused by a CTG repeat expansion in the DMPK gene, and type 2 is caused by a CCTG repeat expansion in the CNBP gene. Type 1 is associated with distal limb, neck flexor, and bulbar weakness and results in different phenotypic subtypes with variable onset from congenital to very late-onset as well as variable signs and symptoms...
October 18, 2018: Neurotherapeutics: the Journal of the American Society for Experimental NeuroTherapeutics
https://www.readbyqxmd.com/read/30341537/prognostic-impact-of-skeletal-muscle-assessed-by-computed-tomography-in-patients-with-acute-myeloid-leukemia
#3
Nobuhiko Nakamura, Soranobu Ninomiya, Takuro Matsumoto, Hiroshi Nakamura, Junichi Kitagawa, Makoto Shiraki, Takeshi Hara, Masahito Shimizu, Hisashi Tsurumi
Skeletal muscle atrophy and loss of adipose tissue, referred to as sarcopenia and adipopenia, respectively, are often observed in cancer patients. We investigated the impact of sarcopenia and adipopenia on clinical outcomes in 90 adult patients with newly diagnosed acute myeloid leukemia (AML) who received induction chemotherapy. Computed tomography (CT) before treatment revealed sarcopenia in 39 patients (43%) and adipopenia in 35 patients (39%). We analyzed the treatment efficacy of induction chemotherapy and survival outcomes...
October 19, 2018: Annals of Hematology
https://www.readbyqxmd.com/read/30341531/radiological-aspect-of-klippel-tr%C3%A3-naunay-syndrome-a-case-series-with-review-of-literature
#4
Osamah Alwalid, Joyman Makamure, Qi-Guang Cheng, Wen-Jun Wu, Chao Yang, Elham Samran, Ping Han, Hui-Min Liang
Klippel-Trénaunay syndrome (KTS) is a rare angio-osteo-hypertrophic syndrome characterized by vascular malformations, soft tissue and/or bone hypertrophy, and varicose veins. For the purpose of describing the imaging findings and elucidating the role of medical imaging in the diagnosis and assessment of patient with KTS, we have reviewed the imaging data of 14 KTS patients. The imaging features on different imaging modalities were analyzed. Unilateral lower limb involvement was evident in 71% of cases (n=10) and bilateral but asymmetric lower limb involvement in the remaining 29% of cases (n=4)...
October 2018: Current medical science
https://www.readbyqxmd.com/read/30340833/adipose-tissue-browning-in-cancer-associated-cachexia-can-be-attenuated-by-inhibition-of-exosome-generation
#5
Wenjun Hu, Zeyuan Ru, Wen Xiao, Zhiyong Xiong, Cheng Wang, Changfei Yuan, Xiaoping Zhang, Hongmei Yang
Cancer-associated cachexia (CAC) is a disorder characterized by unintended weight loss due to skeletal muscle wasting and adipose tissue loss. Although muscle atrophy in this condition has been well studied, the mechanisms underlying adipose tissue loss, which include browning, have not been investigated in detail. In this respect, though recent studies have shown that exosomes from cancer cells can promote lipolysis, the link between exosomes from cancer cells and CAC has not been clearly established. In this study, we investigate if exosomes from Lewis lung carcinoma (LLC) cells can induce lipolysis in vitro (in 3T3-L1 adipocytes) and in vivo (in LLC tumor-bearing mice)...
October 16, 2018: Biochemical and Biophysical Research Communications
https://www.readbyqxmd.com/read/30340467/transplantation-gene-therapy-and-intestinal-pathology-in-mngie-patients-and-mice
#6
Rana Yadak, Max V Boot, Niek P van Til, Dominique Cazals-Hatem, Armin Finkenstedt, Elly Bogaerts, Irenaeus F de Coo, Marianna Bugiani
BACKGROUND: Gastrointestinal complications are the main cause of death in patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Available treatments often restore biochemical homeostasis, but fail to cure gastrointestinal symptoms. METHODS: We evaluated the small intestine neuromuscular pathology of an untreated MNGIE patient and two recipients of hematopoietic stem cells, focusing on enteric neurons and glia. Additionally, we evaluated the intestinal neuromuscular pathology in a mouse model of MNGIE treated with hematopoietic stem cell gene therapy...
October 19, 2018: BMC Gastroenterology
https://www.readbyqxmd.com/read/30338859/apoptotic-changes-in-a-full-lengthened-immobilization-model-of-rat-soleus-muscle
#7
Hye Rim Suh, Eui Ho Park, Sun Wook Moon, Ji Won Kim, Hwi Young Cho, Hee Chul Han
INTRODUCTION: Lengthened immobilization may prevent muscle shortening, and help maintain normal muscle length. However, its apoptotic effects remain unclear. We evaluated the effects of long-term immobilization on apoptotic proteins. METHODS: Rat soleus muscles were immobilized by casting in a neutral (NEUT) or lengthened (LENG) position for 21 days. We evaluated dynamic weight load and muscle atrophy following the 21-day period using hematoxylin and eosin staining...
October 19, 2018: Muscle & Nerve
https://www.readbyqxmd.com/read/30338657/repressors-of-mtorc1-act-to-blunt-the-anabolic-response-to-feeding-in-the-soleus-muscle-of-a-cast-immobilized-mouse-hindlimb
#8
Kevin L Shimkus, Leonard S Jefferson, Bradley S Gordon, Scot R Kimball
We recently reported results showing that cast immobilization of a rat hindlimb rapidly leads to development of anabolic resistance as demonstrated by failure of oral leucine administration to activate the mechanistic target of rapamycin complex 1 (mTORC1) and stimulate protein synthesis in the soleus muscle. The goal of this study was to assess the possible contribution of several mTORC1 regulatory proteins to the development of anabolic resistance. To accomplish this, 14-week-old male C57BL/6 mice (n = 21) were subjected to unilateral cast immobilization of the hindlimb for either 1 or 3 days, and the immobilized limb was compared to its contralateral control...
October 2018: Physiological Reports
https://www.readbyqxmd.com/read/30338442/gne-myopathy-etiology-diagnosis-and-therapeutic-challenges
#9
REVIEW
Nuria Carrillo, May C Malicdan, Marjan Huizing
GNE myopathy, previously known as hereditary inclusion body myopathy (HIBM), or Nonaka myopathy, is a rare autosomal recessive muscle disease characterized by progressive skeletal muscle atrophy. It has an estimated prevalence of 1 to 9:1,000,000. GNE myopathy is caused by mutations in the GNE gene which encodes the rate-limiting enzyme of sialic acid biosynthesis. The pathophysiology of the disease is not entirely understood, but hyposialylation of muscle glycans is thought to play an essential role. The typical presentation is bilateral foot drop caused by weakness of the anterior tibialis muscles with onset in early adulthood...
October 18, 2018: Neurotherapeutics: the Journal of the American Society for Experimental NeuroTherapeutics
https://www.readbyqxmd.com/read/30337525/smyd2-glutathionylation-contributes-to-degradation-of-sarcomeric-proteins
#10
Dhanushka N P Munkanatta Godage, Garrett C VanHecke, Kusal T G Samarasinghe, Han-Zhong Feng, Mark Hiske, Joshua Holcomb, Zhe Yang, Jian-Ping Jin, Charles S Chung, Young-Hoon Ahn
Reactive oxygen species (ROS) contribute to the etiology of multiple muscle-related diseases. There is emerging evidence that cellular stress can lead to destabilization of sarcomeres, the contractile unit of muscle. However, it is incompletely understood how cellular stress induces structural destabilization of sarcomeres. Here we report that glutathionylation of SMYD2 contributes to a loss of myofibril integrity and degradation of sarcomeric proteins mediated by MMP-2 and calpain 1. We used a clickable glutathione approach in a cardiomyocyte cell line and found selective glutathionylation of SMYD2 at Cys13...
October 18, 2018: Nature Communications
https://www.readbyqxmd.com/read/30337273/safety-tolerability-and-preliminary-efficacy-of-an-igf-1-mimetic-in-patients-with-spinal-and-bulbar-muscular-atrophy-a-randomised-placebo-controlled-trial
#11
Christopher Grunseich, Ram Miller, Therese Swan, David J Glass, Mohamed El Mouelhi, Mara Fornaro, Olivier Petricoul, Igor Vostiar, Ronenn Roubenoff, Matthew N Meriggioli, Angela Kokkinis, Robert D Guber, Maher S Budron, John Vissing, Gianni Soraru, Tahseen Mozaffar, Albert Ludolph, John T Kissel, Kenneth H Fischbeck
BACKGROUND: Spinal and bulbar muscular atrophy is an X-linked neuromuscular disease caused by CAG repeat expansion in the androgen receptor gene. Patients with this disease have low concentrations of insulin-like growth factor-1 (IGF-1), and studies of overexpression and administration of IGF-1 showed benefit in a transgenic model; thus the IGF-1 pathway presents as a potential treatment target. We assessed safety, tolerability, and preliminary efficacy of BVS857, an IGF-1 mimetic, in patients with spinal and bulbar muscular atrophy...
October 15, 2018: Lancet Neurology
https://www.readbyqxmd.com/read/30332436/effects-of-activated-vitamin-d-alfacalcidol-and-low-intensity-aerobic-exercise-on-osteopenia-and-muscle-atrophy-in-type-2-diabetes-mellitus-model-rats
#12
Manabu Akagawa, Naohisa Miyakoshi, Yuji Kasukawa, Yuichi Ono, Yusuke Yuasa, Itsuki Nagahata, Chiaki Sato, Hiroyuki Tsuchie, Hiroyuki Nagasawa, Michio Hongo, Yoichi Shimada
Diabetes mellitus causes secondary osteoporosis and muscle atrophy. The ability of alfacalcidol (ALF) and exercise (Exe) to inhibit osteoporosis and muscle atrophy in type 2 diabetes mellitus (T2DM) model rats was examined. Twenty-week-old Otsuka Long-Evans Tokushima Fatty rats were randomized to ALF (orally 0.1 μg/kg/day), Exe (treadmill exercise at 10 m/min, 60 min/day, 5 days/week), Comb (ALF and Exe), and Cont (T2DM control treated with vehicle and no exercise) groups (n = 8-10 per group). Sedentary Long-Evans Tokushima Otsuka rats were used as a non-hyperphagic control...
2018: PloS One
https://www.readbyqxmd.com/read/30328290/protein-imbalance-in-the-development-of-skeletal-muscle-wasting-in-tumour-bearing-mice
#13
Jacob L Brown, David E Lee, Megan E Rosa-Caldwell, Lemuel A Brown, Richard A Perry, Wesley S Haynie, Kendra Huseman, Kavithalakshmi Sataranatarajan, Holly Van Remmen, Tyrone A Washington, Michael P Wiggs, Nicholas P Greene
BACKGROUND: Cancer cachexia occurs in approximately 80% of cancer patients and is a key contributor to cancer-related death. The mechanisms controlling development of tumour-induced muscle wasting are not fully elucidated. Specifically, the progression and development of cancer cachexia are underexplored. Therefore, we examined skeletal muscle protein turnover throughout the development of cancer cachexia in tumour-bearing mice. METHODS: Lewis lung carcinoma (LLC) was injected into the hind flank of C57BL6/J mice at 8 weeks age with tumour allowed to develop for 1, 2, 3, or 4 weeks and compared with PBS injected control...
October 16, 2018: Journal of Cachexia, Sarcopenia and Muscle
https://www.readbyqxmd.com/read/30327977/calpain-inhibition-increases-smn-protein-in-spinal-cord-motoneurons-and-ameliorates-the-spinal-muscular-atrophy-phenotype-in-mice
#14
Sandra de la Fuente, Alba Sansa, Ambika Periyakaruppiah, Ana Garcera, Rosa M Soler
Spinal muscular atrophy (SMA), a leading genetic cause of infant death, is caused by the loss of survival motor neuron 1 (SMN1) gene. SMA is characterized by the degeneration and loss of spinal cord motoneurons (MNs), muscular atrophy, and weakness. SMN2 is the centromeric duplication of the SMN gene, whose numbers of copies determine the intracellular levels of SMN protein and define the disease onset and severity. It has been demonstrated that elevating SMN levels can be an important strategy in treating SMA and can be achieved by several mechanisms, including promotion of protein stability...
October 16, 2018: Molecular Neurobiology
https://www.readbyqxmd.com/read/30327348/shift-from-androgen-to-estrogen-action-causes-abdominal-muscle-fibrosis-atrophy-and-inguinal-hernia-in-a-transgenic-male-mouse-model
#15
Hong Zhao, Ling Zhou, Lin Li, John Coon V, Robert T Chatterton, David C Brooks, Enze Jiang, Li Liu, Xia Xu, Zhiyong Dong, Francesco J DeMayo, Jonah J Stulberg, Warren G Tourtellotte, Serdar E Bulun
Inguinal hernia develops primarily in elderly men, and more than one in four men will undergo inguinal hernia repair during their lifetime. However, the underlying mechanisms behind hernia formation remain unknown. It is known that testosterone and estradiol can regulate skeletal muscle mass. We herein demonstrate that the conversion of testosterone to estradiol by the aromatase enzyme in lower abdominal muscle (LAM) tissue causes intense fibrosis, leading to muscle atrophy and inguinal hernia; an aromatase inhibitor entirely prevents this phenotype...
October 16, 2018: Proceedings of the National Academy of Sciences of the United States of America
https://www.readbyqxmd.com/read/30327220/different-clinicopathological-features-between-japanese-siblings-with-facioscapulohumeral-muscular-dystrophy-2-with-a-novel-nonsense-smchd1-mutation-arg552-%C3%A2
#16
Yasuyuki Ohta, Koh Tadokoro, Ryo Sasaki, Yoshiaki Takahashi, Kota Sato, Mami Takemoto, Nozomi Hishikawa, Jingwei Shang, Toru Yamashita, Yasushi Takehisa, Ichizo Nishino, Koji Abe
Facioscapulohumeral muscular dystrophy (FSHD) 2 is caused by a combination of heterozygous structural maintenance of chromosomes flexible hinge domain containing 1 (SMCHD1) mutation plus DNA hypomethylation on D4Z4. Here we report two Japanese FSHD2 siblings (brother and sister) with a new SMCHD1 nonsense mutation (a heterogeneous c. 1654C > T substitution, leading to a stop codon Arg552∗ ). They showed the typical phenotype of FSHD2 such as asymmetric muscle weakness and atrophy in bilateral facial, scapular and humeral muscles, but different clinicopathological features between them...
October 13, 2018: Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia
https://www.readbyqxmd.com/read/30326173/a-comparison-study-of-prabotulinumtoxina-versus-onabotulinumtoxina-in-myostatin-deficient-mice-with-muscle-hypertrophy
#17
Dong-Ho Bak, Mi Ji Choi, Esther Lee, Tae-Rin Kwon, Jong Hwan Kim, Sang-Hyun Nam, Kyoung-Yun Kim, Seung Won Ahn, Seog-Kyun Mun, Jungtae Na, Beom Joon Kim
Botulinum toxin A (BoNT-A) is used clinically for various muscle disorders and acts by preventing the release of the neurotransmitter acetylcholine into the synapse space. Here, we compared the efficacy of prabotulinumtoxinA (PRA) and onabotulinumtoxinA (ONA) for the reduction of hypertrophy in myostatin-deficiency (Mstn-/- ) mice. Two different BoNT-A products (2.5, 10, and 25 U/kg) were injected to paralyze the hind limb for 2 months, after which sciatic nerve conduction study (NCS), 3D micro-CT, Haematoxylin &Eosin (H&E) and dystrophin staining were conducted...
October 16, 2018: Basic & Clinical Pharmacology & Toxicology
https://www.readbyqxmd.com/read/30325108/cachexia-does-not-induce-loss-of-myonuclei-or-muscle-fibers-during-xenografted-prostate-cancer-in-mice
#18
I M Winje, X Sheng, K-A Hansson, A Solbrå, S Tennøe, F Saatcioglu, J C Bruusgaard, K Gundersen
AIM: Cachexia is a severe wasting disorder involving loss of body- and muscle mass reducing survival and quality of life in cancer patients. We aim at determining if cachexia is a mere perturbation of the protein balance or if the condition also involves a degenerative loss myonuclei within the fiber syncytia or loss of whole muscle fibers. METHODS: We induced cachexia by xenografting PC3 prostate cancer cells in nu/nu mice. Six weeks later, we counted myonuclei by in vivo microscopic imaging of single live fibers in the extensor digitorum longus muscle (EDL), and the EDL, soleus and tibialis anterior muscles were also harvested for ex vivo histology...
October 16, 2018: Acta Physiologica
https://www.readbyqxmd.com/read/30325060/factors-associated-with-survival-in-dogs-with-chronic-kidney-disease
#19
Adam J Rudinsky, Laura M Harjes, Julie Byron, Dennis J Chew, Ramiro E Toribio, Catherine Langston, Valerie J Parker
BACKGROUND: Chronic kidney disease (CKD) is associated with morbidity and mortality in dogs. Plasma fibroblast growth factor-23 (FGF-23) concentration is an independent predictor of CKD progression and survival in cats and people with CKD. OBJECTIVES: To investigate the relationship among FGF-23, parathyroid hormone (PTH), vitamin D metabolites, and other clinical variables with survival time in dogs with CKD. ANIMALS: Twenty-seven azotemic CKD dogs...
October 16, 2018: Journal of Veterinary Internal Medicine
https://www.readbyqxmd.com/read/30324134/microphysiological-3d-model-of-amyotrophic-lateral-sclerosis-als-from-human-ips-derived-muscle-cells-and-optogenetic-motor-neurons
#20
Tatsuya Osaki, Sebastien G M Uzel, Roger D Kamm
Amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease involving loss of motor neurons (MNs) and muscle atrophy, still has no effective treatment, despite much research effort. To provide a platform for testing drug candidates and investigating the pathogenesis of ALS, we developed an ALS-on-a-chip technology (i.e., an ALS motor unit) using three-dimensional skeletal muscle bundles along with induced pluripotent stem cell (iPSC)-derived and light-sensitive channelrhodopsin-2-induced MN spheroids from a patient with sporadic ALS...
October 2018: Science Advances
keyword
keyword
161529
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"